R E Wrishko - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

R E Wrishko

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Therapeutic Drug Monitoring|October 18, 2000

Vancomycin pharmacokinetics and Bayesian estimation in pediatric patientsR E Wrishko, M Levine, D Khoo, et al.

Transplantation|November 5, 1997

Investigation of a possible interaction between ciprofloxacin and cyclosporine in renal transplant patientsR E Wrishko, M Levine, D R Primmett, et al.

Clinical and Translational Science|June 16, 2016

Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult SubjectsW K Kraft, J H Gilmartin, D L Chappell, et al.

Journal of Clinical Pharmacy and Therapeutics|September 12, 2009

Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal diseaseD S Small, R E Wrishko, C S Ernest, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Therapeutic Drug Monitoring|October 18, 2000

Vancomycin pharmacokinetics and Bayesian estimation in pediatric patientsR E Wrishko, M Levine, D Khoo, et al.

Transplantation|November 5, 1997

Investigation of a possible interaction between ciprofloxacin and cyclosporine in renal transplant patientsR E Wrishko, M Levine, D R Primmett, et al.

Clinical and Translational Science|June 16, 2016

Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult SubjectsW K Kraft, J H Gilmartin, D L Chappell, et al.

Journal of Clinical Pharmacy and Therapeutics|September 12, 2009

Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal diseaseD S Small, R E Wrishko, C S Ernest, et al.

Pageof 1